Nursing care
Type 2 Diabetes nursing care: what to assess and what to do first
Written and reviewed by Dana Whitfield, RN, MSN · 5 min read · Updated September 2026
Short answer
Type 2 diabetes is caused by insulin resistance combined with a relative insulin deficiency, not the total absence seen in type 1. Because the pancreas still produces insulin, the intervention that changes long-term outcomes most is weight management and physical activity, with medication added and adjusted around those lifestyle changes rather than replacing them.
What it is and why it happens
Type 2 diabetes develops when peripheral tissues become resistant to insulin's effects and the pancreas cannot compensate with enough additional insulin to maintain normal glucose levels. Unlike type 1, the body still makes insulin, often in above-normal amounts early in the disease, but the cells do not respond to it efficiently. Over time, beta cell function typically declines further, and some patients eventually require insulin therapy, but the underlying problem remains resistance rather than absence.
Risk factors include obesity, sedentary lifestyle, family history, and age over 45, along with conditions like polycystic ovary syndrome and gestational diabetes history. Because insulin resistance is closely tied to excess adipose tissue, particularly visceral fat, weight and activity levels are directly linked to the pathophysiology itself, not just to symptom management. This is why lifestyle intervention is not a supplementary measure here but a treatment aimed at the actual mechanism of the disease.
How it presents — what you will actually see
Onset is gradual, often over years, and many patients are asymptomatic at diagnosis, identified only through routine screening or an incidental elevated glucose. When symptoms do appear, they include fatigue, polyuria, polydipsia, blurred vision, and slow-healing wounds or recurrent infections, particularly skin and urinary tract infections.
Acanthosis nigricans, dark velvety skin patches at the neck or axillae, is a visible marker of insulin resistance and can prompt earlier screening in at-risk patients. Unlike type 1, dramatic weight loss at presentation is uncommon; many patients are overweight or obese at diagnosis. Some patients present in hyperosmolar hyperglycaemic state, with severe hyperglycaemia, dehydration, and altered mental status, but without the significant ketosis seen in type 1, since enough residual insulin remains to suppress ketone production.
Nursing assessment priorities
Assess fasting and random blood glucose, along with HbA1c, to establish baseline control, and review the patient's current medication regimen, whether oral agents, GLP-1 receptor agonists, or insulin. Ask about hypoglycaemia symptoms and episodes, since polypharmacy and variable meal timing increase this risk even in a condition defined by resistance rather than deficiency.
Screen for complications at every visit: check feet for sensation, pulses, and skin integrity, review recent eye exam and renal function results, and ask about erectile dysfunction and cardiovascular symptoms, since macrovascular disease risk is elevated from early in the disease course. Assess weight trend, waist circumference, and current activity level as core data points, not incidental history, because they directly reflect the degree of insulin resistance driving the disease.
Interventions and what to do first
For significant hyperglycaemia, follow the facility's sliding-scale or correction protocol and reassess glucose per protocol timing, but do not treat medication adjustment as the first or only lever. Reinforce and, where appropriate, initiate a structured plan for weight reduction and increased physical activity, since even a modest weight loss of 5 to 7 percent measurably improves insulin sensitivity.
For HHS, prioritise aggressive IV fluid resuscitation before insulin, since profound dehydration is often the more immediately dangerous problem, then begin insulin once fluids are underway and potassium is confirmed adequate. For patients newly started on metformin, teach administration with food to reduce GI upset and confirm renal function has been checked, since metformin is contraindicated in significant renal impairment. Coordinate with the care team on any GLP-1 or SGLT2 therapy, both of which support weight loss alongside glucose control.
Complications to watch for
Macrovascular complications, coronary artery disease, stroke, and peripheral arterial disease, are more prominent early risks in type 2 diabetes than in type 1, reflecting the association between insulin resistance, dyslipidaemia, and hypertension. Monitor blood pressure and lipid panels alongside glucose, since cardiovascular risk reduction is as much a part of diabetes management as glycaemic control.
Microvascular complications, retinopathy, nephropathy, and peripheral neuropathy, develop over years and require regular screening even in patients who feel well. Diabetic foot complications deserve particular attention: reduced sensation combined with impaired circulation means minor injuries can progress to ulceration without the patient noticing. HHS remains the most acute life-threatening complication and carries a higher mortality rate than DKA due to the severity of dehydration and the older, often comorbid population it typically affects.
Patient teaching before discharge
Lead discharge teaching with weight and activity goals before medication instructions, since these interventions address the resistance itself and can reduce or delay the need for additional drug therapy. Set realistic, specific targets, such as 150 minutes of moderate activity per week and a modest, sustainable calorie reduction, rather than vague advice to eat better or move more.
Cover medication administration and timing, hypoglycaemia recognition even though the baseline risk is lower than in type 1, and the importance of home glucose monitoring frequency appropriate to the regimen. Teach foot care, including daily inspection and properly fitted footwear, and confirm the patient understands the schedule for eye, kidney, and cardiovascular screening. Reinforce that type 2 diabetes is progressive but that sustained weight and activity changes can meaningfully alter its trajectory, which is not equally true once a patient has lost all endogenous insulin production.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our endocrine practice questions are the closest set to what this page covers.
Common questions
What is the main difference between type 1 and type 2 diabetes for nursing care?
Type 1 involves an absolute lack of insulin, so insulin can never be withheld. Type 2 involves insulin resistance with relative deficiency, so weight management and activity are central interventions alongside medication rather than insulin replacement alone.
Why is weight loss emphasised so heavily in type 2 diabetes teaching?
Excess adipose tissue, particularly visceral fat, directly drives insulin resistance, the core mechanism of the disease. A weight loss of 5 to 7 percent can measurably improve insulin sensitivity, addressing the problem rather than only its symptoms.
How does HHS differ from DKA in type 2 diabetes?
HHS involves severe hyperglycaemia and profound dehydration without significant ketosis, because residual insulin production suppresses ketone formation. Fluid resuscitation takes priority before insulin, and HHS carries a higher mortality rate than DKA due to the severity of dehydration and typical patient comorbidities.
What should be assessed before starting metformin?
Renal function must be checked, since metformin is contraindicated in significant renal impairment due to lactic acidosis risk. Patients should also be taught to take it with food to reduce gastrointestinal upset.
How do NCLEX questions distinguish type 2 diabetes from type 1?
Questions often test recognition that type 2 patients retain some insulin production, making DKA less likely and HHS more likely during acute decompensation. They also test prioritisation of lifestyle intervention alongside, not instead of, pharmacologic treatment.